Rational approach to a conglomerate-forming propranolol derivative: pointed modifications of the crystal structure

The crystal structure of racemic propranolol hydrochloride was reinvestigated and the main supramolecular solid-state motif (infinite homochiral chains) was found. Changes in the size of the central anion are accompanied by substantial differences in crystal packing leading to a homochiral crystal lattice of racemic conglomerate.

[1]  G. Coquerel,et al.  A Priori Assessment of the Maximum Possible Entrainment Effect Attainable during Preferential Crystallization. The Case of the Simultaneous Resolution of (.+-.)-Ephedrine and (.+-.)-Mandelic Acid , 2004 .

[2]  G. Coquerel,et al.  How far can an unstable racemic compound affect the performances of preferential crystallization? Example with (R) and (S)-α-methylbenzylamine chloroacetate† , 1998 .

[3]  H. Aboul‐Enein,et al.  The Impact of Stereochemistry on Drug Development and Use , 1997 .

[4]  K. Stoschitzky,et al.  Stereoselective Vascular Effects of the (R)- and (S)-Enantiomers of Propranolol and Atenolol , 1995, Journal of cardiovascular pharmacology.

[5]  S. Neau,et al.  Melting point phase diagrams of free base and hydrochloride salts of bevantolol, pindolol and propranolol , 1993 .

[6]  G. H. Dewar,et al.  The steric factor in medicinal chemistry , 1993 .

[7]  C. Giacovazzo,et al.  E‐map improvement in direct procedures , 1991 .

[8]  P. Lehmann.  Stereoisomerism and drug action , 1986 .

[9]  G. M. Goodwin,et al.  A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5‐HT1 and 5‐HT2 receptors , 1985, British journal of pharmacology.

[10]  Jean Jacques,et al.  Enantiomers, Racemates, and Resolutions , 1981 .

[11]  M. Brienne,et al.  Optical resolution by direct crystallization of enantiomer mixtures , 1980 .

[12]  H. Ammon,et al.  The crystal structures of dichloroisoproterenol, propranolol and propranolol hydrochloride , 1977 .

[13]  M. Cotrait,et al.  Conformations cristallines d'adrnolytiques -bloquants: propranolol et alprnolol , 1973 .

[14]  A. Barrett,et al.  The biological properties of the optical isomers of propranolol and their effects on cardiac arrhythmias , 1968, British journal of pharmacology.

[15]  R. Shanks,et al.  Optical Isomers of Propranolol , 1966, Nature.